At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
Low Dose Naltrexone +1 moredrug
Likely dose
Low Dose Naltrexone 4.5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Low Dose Naltrexone in Fibromyalgia
In Brief
A clinical study evaluating Low Dose Naltrexone and Placebo - sugar pill for Fibromyalgia and Persian Gulf Syndrome. Completed, enrolled 53 participants across 1 site.
Detailed Summary
Low Dose Naltrexone (LDN) has been reported anecdotally to reduce the symptoms of Fibromyalgia, a Chronic Multisystem Illness. The drug may work by regulating natural pain-reducing systems. In this study, we will administer both LDN and placebo to a small group of individuals with Fibromyalgia and Gulf War Syndrome, both Chronic Multisymptom Illnesses, to assess the drug's efficacy in treating the condition.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia, Persian Gulf Syndrome
CountriesUnited States
CollaboratorsAmerican Fibromyalgia Syndrome Association
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2007
First PostedDec 2007
Primary CompletionJan 2010
TodayJul 2026
First PostedDec 6, 2007
Enrollment StartJun 1, 2007
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 18.6 years ago
Interventions
Low Dose Naltrexonedrug
3-4.5mg Naltrexone once daily
Placebo - sugar pilldrug
Placebo pill once daily